Cargando…
No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549133/ https://www.ncbi.nlm.nih.gov/pubmed/33116665 http://dx.doi.org/10.2147/IDR.S284483 |
_version_ | 1783592742785384448 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7549133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75491332020-10-27 No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] Infect Drug Resist Erratum Dove 2020-10-07 /pmc/articles/PMC7549133/ /pubmed/33116665 http://dx.doi.org/10.2147/IDR.S284483 Text en © 2020 Hamed et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Erratum No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] |
title | No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] |
title_full | No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] |
title_fullStr | No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] |
title_full_unstemmed | No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] |
title_short | No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] |
title_sort | no evidence for ceftobiprole-induced immune hemolytic anemia in three phase 3 clinical trials [erratum] |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549133/ https://www.ncbi.nlm.nih.gov/pubmed/33116665 http://dx.doi.org/10.2147/IDR.S284483 |